TC
NVO

Tacita Capital’s Novo Nordisk NVO Stock Holding History

Tacita Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.21K Hold
169
– – ﹤0.01% 229
2025
Q4 		$8.6K Hold
169
– – 0.01% 201
2025
Q3 		$9.38K Hold
169
– – 0.01% 199
2025
Q2 		$11.7K Hold
169
– – 0.01% 191
2025
Q1 		$11.7K Hold
169
– – 0.01% 183
2024
Q4 		$14.5K Hold
169
– – 0.01% 178
2024
Q3 		$20.1K Hold
169
– – 0.01% 167
2024
Q2 		$24.1K Hold
169
– – 0.02% 168
2024
Q1 		$21.7K Sell
169
-67
-28% -$7.98K 0.02% 173
2023
Q4 		$24.4K Buy
+236
New +$23.3K 0.02% 172

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Tacita Capital's NVO Position: Q1 2026 in Review

Tacita Capital held its Novo Nordisk (NVO) position steady in Q1 2026 at 169 shares worth $6.21K. The position accounts for ﹤0.01% of the portfolio, ranked #229.

Tacita Capital first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $24.4K in Q4 2023. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Tacita Capital held 169 shares of Novo Nordisk worth $6.21K as of Q1 2026.
  • Tacita Capital left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up ﹤0.01% of Tacita Capital's portfolio in Q1 2026, its #229 holding.
  • Tacita Capital first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
  • Tacita Capital's Novo Nordisk position peaked at $24.4K in Q4 2023.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Tacita Capital's 13F filing for Q1 2026, filed 7 May 2026.